1000004104

Jubilant Life Science

1126.70
+3.40 (0.30%) tick NSE

Last updated on 19 Jun 2025 04:25 PM

Returns
-0.01%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

17888.59

Earning Per Share

1.99

Dividend Yield

0.88%

P/E Ratio

285.68

P/B Ratio

7.72

Debt to Equity

0.15

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978. The Company name was thereafter changed to 'Jubliant Organosys Limited' in November, 2001 and to 'Jubilant Life Sciences Limited' in October, 2009 and the Company attained its new name 'Jubilant Pharmova Limited' in February, 2021. Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions. The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs. The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA.

Similar Companies